[Helsinki Heart Study].
Sekiya
M
M
Department of Metabolic Diseases, Hospital, Faculty of Medicine, University of Tokyo.
Ishibashi
S
S
D000328:Adult; D003327:Coronary Disease / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D005387:Finland; D015248:Gemfibrozil / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors; D016896:Treatment Outcome
D000960:Hypolipidemic Agents; D008055:Lipids; D015248:Gemfibrozil